Analyst consensus rating
Caribou Biosciences Analyst Rating: none
Direct answer
Caribou Biosciences's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.86.
Forecast evidence checked September 4, 2026.
Get free Caribou Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.57
- Average price target
- $11.86
- High price target
- $32.00
- Low price target
- $4.00
- Low target gap
- +154.8%
- Target upside
- +655.2%
- High target gap
- +1,938.2%
- Target range width
- 1,783.4%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 4, 2026
- Valid through
- September 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Caribou Biosciences?
Caribou Biosciences has a verified none consensus. The same dataset has an average price target of $11.86.
How far are Caribou Biosciences's low and high targets from the recorded price?
The low target implies +154.8%, while the high target implies +1,938.2%.
How many analysts are included in Caribou Biosciences's consensus?
The verified consensus includes 7 analysts.
How is Caribou Biosciences's target upside or downside calculated?
The average target of $11.86 is divided by the recorded price of $1.57, then one is subtracted to produce +655.2%. This does not guarantee a future return.
When was Caribou Biosciences's analyst forecast verified?
The data was verified on 2026-09-04. The dataset is valid through 2026-09-11.